Security Shot (SHOT) has made a daring transfer into cryptocurrency by allocating $25 million to BONK (BONK), the fifth-largest memecoin with a market cap of over $2 billion. Final week, the Nasdaq-listed firm the creation of a company BONK treasury, receiving $25 million in tokens via a strategic alliance with BONK founding contributors, whereas issuing $35 million in convertible most well-liked shares as consideration.
This positions Security Shot amongst an rising variety of corporations adopting altcoin treasury methods past Bitcoin (BTCUSD). Current company strikes embrace Bit Origin (BTOG) arranging $500 million for Dogecoin (DOGEUSD) accumulation and SharpLink Gaming (SBET) disclosing practically 600,000 in Ethereum (ETHUSD) holdings. Security Shot CEO Jarrett Boon referred to as it “the primary stage of a much wider company evolution for our firm” and a daring step into digital property.
Security Shot selected BONK for its Solana (SOLUSD) blockchain basis, citing high-speed, low-cost transaction capabilities that present benefits over Ethereum-based opponents like Shiba Inu (SHIBUSD) and Pepe (PEPE), which wrestle with community congestion and elevated charges.
Notably, Security Shot’s core enterprise focuses on drinks designed to cut back blood alcohol content material, producing income via direct-to-consumer gross sales and retail partnerships. Whereas the corporate has over $15 million in money reserves, this crypto pivot represents a dramatic shift from its healthcare-focused mission. Although company crypto adoption is accelerating, traders ought to fastidiously contemplate whether or not this speculative wager aligns with their danger tolerance earlier than buying SHOT shares.
Security Shot presents substantial dangers for potential traders, at the same time as latest medical trials confirmed important blood alcohol content material (BAC) discount. As of June 2025, Security Shot held simply $466,791 in money with adverse working capital of $3.0 million, elevating substantial doubt about its capacity to proceed as a going concern. This monetary misery follows years of mounting analysis and growth bills, together with $1.6 million in 2023 alone, whereas producing minimal income since launching its Positive Shot complement in December 2023.
